바이오인

The ETP Nanomedicine  has discussed the needs for novel strategic activities in the area of
nanotechnologies for medicine and health for more than 2 years now, taking into account the current developments in the Medtech and the Pharmaceutical sector. The ETPN published an advisory roadmap document in 2009 which outlined the industrially driven implementation plans for Nanomedicinal products in the area of diagnostics, pharmaceutics and egenerative medicine. For further guidance for this white paper the ETPN recently launched an online consultation to the Nanomedicine community to gather input on the needed innovations in the upcoming framework programme.